IL169121A - Peptide nanotubes composed of specific aromatic homodipeptides and methods for their preparation - Google Patents
Peptide nanotubes composed of specific aromatic homodipeptides and methods for their preparationInfo
- Publication number
- IL169121A IL169121A IL169121A IL16912105A IL169121A IL 169121 A IL169121 A IL 169121A IL 169121 A IL169121 A IL 169121A IL 16912105 A IL16912105 A IL 16912105A IL 169121 A IL169121 A IL 169121A
- Authority
- IL
- Israel
- Prior art keywords
- nanostructure
- discrete
- phe
- phg
- nanotube
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
Claims (12)
1. A discrete nanotube composed of a plurality of aromatic homodipeptides selected from the group consisting of diphenylalanine, di(Pentafluro-Phenylalanine), di(Iodo-Phenylalanine) and dinaphthylalanine.
2. The discrete nanostructure of claim 1, wherein the nanostructure comprises a nanotube which does not exceed 500 nm in diameter.
3. The discrete nanostructure of claim 1, wherein the nanostructure comprises a nanotube being at least 1 nm in length.
4. The discrete nanostructure of claim 1 , wherein at least one amino acid of said aromatic homodipeptides is a D-amino acid.
5. The discrete nanostructure of claim 1, wherein at least one amino acid of said aromatic homodipeptides is an L-amino acid.
6. The discrete nanostructure of claim 1, wherein the nanostructure is stable at a temperature range of 4-400 °C.
7. A discrete nanosphere composed of a plurality of aromaticpeptides selected from the group consisting of diphenylglycine and cysteinediphenylalanine.
8. A method of generating a discrete nanostructure, the method comprising incubating a plurality of aromatic peptides selected from the group consisting of diphenylalanine, di(Pentafluro-Phenylalanine), di(Iodo-Phenylalanine), dinaphthylalanine, diphenylglycine and cysteinediphenylalanine under conditions which favor formation of the discrete nanostructure, wherein said conditions comprise dissolving the plurality of aromatic peptides in l ,l,l ,3,3,3-hexafluoro-2-propanol at a concentration of 100 mg/ml and subsequent dilution in water to a final concentration of 2 mg/ml, thereby generating the discrete nanostructure.
9. The method of claim 8, wherein the discrete nanostructure comprises a nanotube which does not exceed 500 nm in diameter.
10. The method of claim 8, wherein the discrete nanostructure comprises a nanotube which is at least 1 nm in length.
11. 1 1. The method of claim 8, wherein the nanostructure is a nanotube and said plurality of aromatic peptides comprise diphenylalanine.
12. The method of claim 8, wherein the nanostructure is a nanosphere and said plurality of aromatic peptides comprise diphenylglycine. Patent Attorney G.E. Ehrlich (1995) Ltd. 11 Menachem Begin Street 52 521 Ramat Gan vv nvers y . ee - -o . - - amo e vv nvers y . - - IKl- Eg^E] former KLVEFy inhibitor inhibitor H2N— CH, CH, Fig.9a amo e vv nvers y . - - 2 urn Fig.10a Fig.10b Fig.11a Fig.11b 50-100 100-150 150-200200-250250-300 Fig.11c Nanotubes diameter (nm) v y . ee - - o NH2-D-Phe-D-Phe-COOH NH2-L-Phe-L-Trp-COOH + Proteinase K Fig.12a Fig.12b Fi9- 14 . - - O O -CH-C- H N-CH-C-OH CH-C- HM-CH-C-OH CH, CH, NH2-Phe-Phe-COOH NH2-Phg-Phg-COOH Fig.15a Fig.15b Fig.15c Fig.15d vv v y . ee - - o amo e vv nvers y . ee - - o o 3 nOc u O sLo- °o o O r o O O Q.O; r100fnjn O 100 nm ; \. 7- Phg-Phg+10%TFA Phg-Phg+1M NaOH Fig.17a Fig.17b O O ■ I H I III H II CH— C-fj-CH-C-fj-CH-C-OH I CH CH ♦ *1μΓΠ NH2-Cys-Phe-Phe-COOH Fig.18a Fig.18b vv vers y . ee - - o Fig.19b Fig.19c Ramot At Tel Aviv University Ltd. Sheet -13- of 15 o II H II H^l CH— C N CH— C OH CHc CHc Fig.20 Ramot At Tel Aviv University Ltd. Sheet -14- of 15 Fig. 21 Ramot At Tel Aviv University Ltd. Sheet -15- of 15 Fig. 22C Fig. 22D
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL169121A IL169121A (en) | 2002-12-09 | 2005-06-09 | Peptide nanotubes composed of specific aromatic homodipeptides and methods for their preparation |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43170902P | 2002-12-09 | 2002-12-09 | |
| US45837803P | 2003-03-31 | 2003-03-31 | |
| PCT/IL2003/001045 WO2004052773A2 (en) | 2002-12-09 | 2003-12-09 | Peptide nanostructures, methods for their preparation and use |
| IL169121A IL169121A (en) | 2002-12-09 | 2005-06-09 | Peptide nanotubes composed of specific aromatic homodipeptides and methods for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL169121A true IL169121A (en) | 2012-05-31 |
Family
ID=46467055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL169121A IL169121A (en) | 2002-12-09 | 2005-06-09 | Peptide nanotubes composed of specific aromatic homodipeptides and methods for their preparation |
Country Status (1)
| Country | Link |
|---|---|
| IL (1) | IL169121A (en) |
-
2005
- 2005-06-09 IL IL169121A patent/IL169121A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Reches et al. | Self‐assembly of peptide nanotubes and amyloid‐like structures by charged‐termini‐capped diphenylalanine peptide analogues | |
| JP2005505579A5 (en) | ||
| Ahn et al. | Peptidomimetics and peptide backbone modifications | |
| EP2272825A3 (en) | N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation | |
| AU2003286404A1 (en) | Peptide nanostructures, methods for their preparation and use | |
| WO2001078503A3 (en) | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins | |
| EP3202779A3 (en) | Long-acting hgh polypeptides and uses thereof | |
| EP2071028A3 (en) | HLA-DR-binding antigen peptide derived from WT1 | |
| EA200702392A1 (en) | PEPTID, A COMPOSITION ON ITS BASIS, A STENT WITH ITS USE FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED BY INFLAMMATORY PROCESSES, AND A METHOD OF MANUFACTURING THE INDICATED STENT | |
| Waugh et al. | A review of the collision‐induced dissociations of deprotonated dipeptides and tripeptides. An aid to structure determination | |
| CN108893515B (en) | High F value oligopeptide and preparation method thereof | |
| Taylor | Chemoenzymatic synthesis of peptidyl 3, 4-dihydroxyphenylalanine for structure–activity relationships in marine invertebrate polypeptides | |
| IL169121A (en) | Peptide nanotubes composed of specific aromatic homodipeptides and methods for their preparation | |
| Acartürk et al. | Comparison of vaginal aminopeptidase enzymatic activities in various animals and in humans | |
| EP2399599A3 (en) | Mucin hypersecretion inhibitors and methods of use | |
| WO2004099240B1 (en) | Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars) | |
| WO1998012225A3 (en) | Process for producing a plasma protein-containing medicament | |
| Hojo et al. | Solid‐phase peptide synthesis using nanoparticulate amino acids in water | |
| WO2001046220A2 (en) | Bioactive oligopeptides | |
| Ogawa | A pair of pyrene groups as a conformational probe for antiparallel β-sheet structure formed in cyclic peptides | |
| WO2007029262A3 (en) | Compositions and methods using same for the detection of viruses | |
| Hashimoto et al. | β-Phenylselenoalanine as a dehydroalanine precursor–efficient synthesis of alternariolide (AM-toxin I) | |
| Koide et al. | Investigation of the dimethylsulfoxide-trifluoroacetic acid oxidation system for the synthesis of cystine-containing peptides | |
| Rohlfing et al. | Evolutionary processes possibly limiting the kinds of amino acids in protein to twenty: a review | |
| AU2001263267A1 (en) | Synthesis of n-(n-(3,3-dimethylbutyl)-l-alpha-aspartyl)-l-phenylalanine 1-methylester using l-alpha-aspartyl-l-phenylalanine 1-methyl ester precursors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed |